<乌鸦传媒>Clinical Challenges: Treating Breast Cancer in the 'Very Old' Aggressive treatment may still be an option Jan 09, 2023
<乌鸦传媒>Clinical Challenges: Targeting Menin in Acute Myeloid Leukemia Early trials of novel inhibitors show promise in selected patients Jan 04, 2023
<乌鸦传媒>Clinical Challenges: Treating AML With IDH1 and IDH2 Mutations Development of IDH inhibitors has changed the treatment landscape Dec 27, 2022
<乌鸦传媒>Clinical Challenges: Proper Sequencing for Metastatic HER2-Positive Breast Cancer Getting it right is crucial in choosing therapy Dec 27, 2022
<乌鸦传媒>Clinical Challenges: Treating AML in Older and Unfit Patients Lower-intensity therapies now available and effective for these patients Dec 19, 2022
<乌鸦传媒>Clinical Challenge: HER2-Positive Breast Cancer in Younger Women Young women with HER2-positive breast cancer have similar outcomes as older women Dec 13, 2022
<乌鸦传媒>Clinical Challenges: Test Your Knowledge About Adult-Onset Still's Disease A three-question quiz on diagnosis, therapeutic options, and other aspects of disease management Dec 06, 2022
<乌鸦传媒>Clinical Challenges: Managing Adult-Onset Still's Disease Immunomodulatory agents are shaping up for rare inflammatory disease Dec 06, 2022
<乌鸦传媒>Clinical Challenges: Treating Recovered Dilated Cardiomyopathy Optimal strategies aren't well established, but continuing medications has a clear mandate Dec 05, 2022
<乌鸦传媒>Clinical Challenges: Expanding Treatment Options for Dry Eye Disease A key focus is on improving the efficacy and tolerability of topicals Nov 28, 2022
<乌鸦传媒>Clinical Challenges: Therapeutic Options for AOSD The disease is "reasonably treatable" if patients start on medications quickly Nov 25, 2022
<乌鸦传媒>Clinical Challenges: When Diagnosing Adult-Onset Still's Disease, Think Zebra This rare disease can often initially look like an infection or cancer Nov 18, 2022
<乌鸦传媒>Clinical Challenges: Dry Eye Disease Can Present Many Faces Understanding links between comorbidities and dry eye phenotypes can help individualize treatment Nov 11, 2022
<乌鸦传媒>Clinical Challenges: Tackling Dry Eye Disease Managing a frequent contributor to dry eye -- meibomian gland dysfunction Nov 04, 2022
<乌鸦传媒>Clinical Challenges: Long-Term Management of Thyroid Eye Disease Recently approved and investigational nonsurgical treatment options are the future of care Oct 14, 2022
<乌鸦传媒>Clinical Challenges: Test Your Knowledge on Metastatic Breast Cancer A three-question quiz on HER2-low disease, brain metastases, and progression on CDK4/6 inhibitors Sep 30, 2022
<乌鸦传媒>Clinical Challenges: Options After CDK4/6 Inhibitors in Breast Cancer Rapidly changing landscape has brought new targeted agents and made staying up-to-date vital Sep 30, 2022
<乌鸦传媒>Clinical Challenges: The Low-Down on HER2-Low The new category could encompass a majority of metastatic, unresectable breast cancers Sep 09, 2022
<乌鸦传媒>Clinical Challenges: Knowing When It's Thyroid Eye Disease Early, specialized treatment is key following diagnosis Aug 15, 2022
<乌鸦传媒>Clinical Challenges: New Hope for Huntington's Disease Chorea Undertreated motor symptoms may have a new option on the horizon Jul 13, 2022
<乌鸦传媒>Clinical Challenges: Test Your Knowledge About Inherited Retinal Diseases A three-question quiz on common IRDs, gene therapy research, and clinical trial participation Jul 07, 2022
<乌鸦传媒>Clinical Challenges: NfL as Emerging Biomarker in Huntington's Disease Neuron-specific protein might allow for earlier treatment, better prognostication Jun 29, 2022
<乌鸦传媒>Clinical Challenges: Gene Replacement Therapy for Inherited Retinal Diseases Experts discuss the most promising research advances to delay disease progression/restore vision Jun 21, 2022
<乌鸦传媒>Clinical Challenges: Use of Adjuvant Immunotherapy in RCC More data awaited, but until then, decisions should be made on case-by-case basis Jun 16, 2022
<乌鸦传媒>Clinical Challenges: Tackling Suicidality in Huntington's Disease Start early with attention to patients' family members and watch periods of elevated risk Jun 15, 2022
<乌鸦传媒>Common Inherited Retinal Diseases: Presentation, Diagnosis, Treatment Experts review approaches to retinitis pigmentosa, Stargardt disease, and choroideremia Jun 06, 2022
<乌鸦传媒>Clinical Challenges: CVD Polypills Left Out in the Cold Yet there is still interest in fixed-dose combination therapies May 02, 2022
<乌鸦传媒>Clinical Challenges: Test Your Knowledge of ASCVD A three-part quiz on recent controversies about statins, aspirin, and polypills May 02, 2022
<乌鸦传媒>Clinical Challenges: Aspirin's Role in Subclinical Atherosclerosis Should people with atherosclerosis on imaging get a leg up on treatment? Apr 25, 2022
<乌鸦传媒>Clinical Challenges: Test Your Knowledge of Cardiomyopathy A three-part quiz on exercise, cardiotoxicity after cancer therapy, and COVID long-haulers Apr 21, 2022
<乌鸦传媒>Clinical Challenges: Implementing More Guideline-Endorsed SGLT2i Use New strategies needed to ensure all are on board with fourth pillar of HF treatment Apr 11, 2022
<乌鸦传媒>Clinical Challenges: Test Your Knowledge on Porphyria A three-part quiz on treating acute hepatic porphyria and erythropoietic protoporphyria Jan 05, 2022
<乌鸦传媒>Clinical Challenges: Managing Erythropoietic Protoporphyria First pharmaceutical option has changed the field, but uptake has been less than universal Jan 05, 2022
<乌鸦传媒>Clinical Challenges: Specialist Palliative Care in Acute Myeloid Leukemia Advocates say patients would benefit greatly from more referrals Dec 22, 2021
<乌鸦传媒>Clinical Challenges: Using MRD in Chronic Lymphocytic Leukemia Management Early indications that it could be used to guide the length of fixed-duration therapy Dec 22, 2021
<乌鸦传媒>Clinical Challenge: Overdiagnosis of DCIS and High-Risk Breast Lesions Working across disciplines and ongoing research might help Dec 21, 2021
<乌鸦传媒>Clinical Challenges: Chemoprevention for Early Breast Cancer Uptake low, but patient education and lower dosing can help Dec 14, 2021
<乌鸦传媒>Clinical Challenges: Complications of CLL Side effects of novel treatments differ from those of traditional chemotherapy Dec 13, 2021
<乌鸦传媒>Clinical Challenge: Urinary Diversion Methods in Bladder Cancer Patients should be well informed about pros, cons of the options Dec 06, 2021
<乌鸦传媒>Clinical Challenges: Back to Square One in Anticoagulation for PCI? With heparin prevailing, where does bivalirudin stand? Dec 02, 2021
